, Volume 9, Issue 6, pp 424–447 | Cite as

Clotrimazole: A Review of its Antifungal Activity and Therapeutic Efficacy

  • Phyllis R. Sawyer
  • R. N. Brogden
  • K. M. Pinder
  • T. M. Speight
  • G. S. Avery
Evaluations on New Drugs


Clotrimazole2, a synthetic imidazole derivative, is primarily used locally in the treatment of vaginal and skin infections due to yeasts and dermatophytes. In vitro, it is most active against Candida spp., Trichophyton spp., Microsporum spp. and Malazzesia furfur (Pityrosporon orbiculare). In addition, it has some in vitro activity against certain Gram-positive bacteria, and at very high concentrations has activity against Trichomonas spp.

In the treatment of vaginal candidiasis, clotrimazole vaginal tablets have produced cure rates comparable with those of conventional nystatin vaginal tablets. There have been no published comparisons with nystatin vaginal cream or foaming vaginal tablets — nystatin dosage forms preferred by some clinicians. Clotrimazole has also been successful in patients who had failed to respond to other antifungal agents such as nystatin and amphotericin B. Results in trichomonal vaginitis are not impressive.

Skin infections caused by Candida or dermatophytes have been effectively treated with topical application of clotrimazole. In comparative trials, clotrimazole cream has been as effective as Whitfleld’s ointment and tolnaftate in the treatment of dermatophytoses, and as effective as nystatin in cutaneous candidiasis. Clotrimazole topical preparations are generally well tolerated, but local irritation has necessitated withdrawal of therapy in a few cases.

Candidal septicemia and urinary and pulmonary candidiasis have been cured with oral clotrimazole therapy. Results in other types of serious fungal infections, including pulmonary aspergillosis, have been disappointing. A limiting factor in oral clotrimazole therapy is the high incidence of gastro-intestinal disturbances and neurological reactions.

Key Words

Antifungal agents Candidiasis Clotrimazole Dermatophytoses Tinea 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aal, H.A. and Moawad, M.K.: Clinical experience with Canesten cream (Bay b 5097) against dermatophytes in Egypt. Mykosen 16: 369 (1973).PubMedCrossRefGoogle Scholar
  2. Bewick, M. and Raper, D.A.: The diagnosis of systemic fungal infection in renal transplant patients and treatment with clotrimazole. Postgraduate Medical Journal 50 (Suppl. 1): 34 (1974).PubMedGoogle Scholar
  3. Bodenhoff, J.: A new antimycotic from Bayer AG, Bay b 5097. Acta Pathologica et Microbiologica Scandinavica 79: 345 (1971).Google Scholar
  4. Bolt, H.M. and Kappus, H.: Effect of clotrimazole treatment on the demethylation of mestranol. Hormone and Metabolism Research 5: 234(1973).CrossRefGoogle Scholar
  5. Buchet, K.H.; Draber, W.; Regel, E. and Plempel, M.: Syntheses and properties of clotrimazole and other antimycotic 1-triphenylmethyl imidazoles. Drugs Made in Germany 75: 79 (1972).Google Scholar
  6. Burgess, M.A. and Bodey, G.P.: Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. Antimicrobial Agents and Chemotherapy 2: 423 (1972).PubMedCrossRefGoogle Scholar
  7. Cartwright, R.Y.: Clotrimazole in the treatment of acute and ‘resistant’ vaginal candidiasis. Postgraduate Medical Journal 50 (Suppl.1): 90(1974).PubMedGoogle Scholar
  8. Cartwright, R.Y.; Shaldon, C. and Hall, G.H.: Urinary candidiasis after renal transplantation. British Medical Journal 2: 351 (1972).PubMedCrossRefGoogle Scholar
  9. Cho, N.; Saito, T.; Fukada, M.; Sato, I.; Kurakata, H. and Matsuhashi, K.: Clinical studies on clotrimazole as antifungal therapy in obstetrics and gynecology. Current Medical Research and Opinion 2: 1 (1974).PubMedCrossRefGoogle Scholar
  10. Clayton, Y.M. and Connor, B.L.: Clinical trial of clotrimazole in the treatment of superficial fungal infections. Postgraduate Medical Journal 50 (Suppl. 1): 66 (1974).PubMedGoogle Scholar
  11. Cohen, M.; Harkness, R.A.; Renz, M. and Farquhar, J. W.: Trials of the use of clotrimazole in the treatment of oral candidiasis in newborn babies. Postgraduate Medical Journal 50 (Suppl. 1): 28(1974).PubMedGoogle Scholar
  12. Comaish, J.S.: Double-blind comparison of clotrimazole with Whitfield’s and nystatin ointments. Postgraduate Medical Journal 50 (Suppl. 1): 73 (1974).PubMedGoogle Scholar
  13. Couchman, J.M.: A preliminary report on a trial of clotrimazole against vaginal candidiasis in venereology. Postgrad. med. J. 50 (Suppl. 1): 93 (1974).PubMedGoogle Scholar
  14. Crompton, G.K. and Milne, U.R.: Treatment of bronchopulmonary aspergillosis with clotrimazole. British Journal of Diseases of the Chest 67: 301 (1973).PubMedCrossRefGoogle Scholar
  15. David, L.M.; Veien, N.K.; Schmidt, J.D.; Murtishaw, W. and Smith E.B.: Topical clotrimazole in dermatophytosis. Current Therapeutic Research 15: 133 (1973).PubMedGoogle Scholar
  16. Dogliotti, M. and Bisset, E.A.: Tinea capitis in black children. South African Medical Journal 48: 2215 (1974).PubMedGoogle Scholar
  17. Drouchet, E.: Systemic mycoses — an acute diagnostic and therapeutic problem. Clinical Excerpts 35: 1219 (1973).Google Scholar
  18. Duhm, B.; Maul, W.; Medenwald, H.; Patzche, K.; Wagner, L.A. and Oberste-Lehn, H.: Pharmacokinetics of topically applied Bis phenyl-(2-chlorophenyl)-1-imidazolyl-methane-[14C]. Drugs Made in Germany 15: 99 (1972).Google Scholar
  19. Dunster, G.D.: Vaginal candidiasis in pregnancy — a trial of clotrimazole Postgraduate Medical Journal 50 (Suppl. 1): 86 (1974).PubMedGoogle Scholar
  20. El Sheikh, M.: Laboratory and clinical experience with clotrimazole (Bay b 5097). Sabouraudia 10: 210 (1972).Google Scholar
  21. El Zawahry, M. and Moawad, M.K.: Topical treatment of dermatomycoses with Canesten cream, and new antimycotic compound. Mykosen 16: 363 (1973).PubMedCrossRefGoogle Scholar
  22. Evans, E.G.V.; Watson, D.A. and Mathews, N.R.: Pulmonary aspergillomata in a child treated with clotrimazole. British Medical Journal 4: 599 (1971).PubMedCrossRefGoogle Scholar
  23. Fredriksson, T.: Topical treatment with Bay b 5097, a new broad spectrum antimycotic agent. British Journal of Dermatology 86: 628 (1972).PubMedCrossRefGoogle Scholar
  24. Freis, A.: The tolerance of clotrimazole on topical application. Drugs Made in Germany 15: 120 (1972).Google Scholar
  25. Gillesberger, W. and Engelhardt, A.: An open trial of topical clotrimazole in dermatomycoses. Postgraduate Medical Journal 50 (Suppl. 1): 61 (1974).PubMedGoogle Scholar
  26. Gip, L.: Topical treatment with clotrimazole in dermatomycosis. Current Therapeutic Research 16: 27 (1974a).PubMedGoogle Scholar
  27. Gip, L.: The topical therapy of pityriasis versicolor with clotrimazole. Postgraduate Medical Journal 50 (Suppl. 1): 59 (1974b).PubMedGoogle Scholar
  28. Hall-Smith, P.: Dermatomycoses: a brief history of therapy and initial results with clotrimazole. Postgraduate Medical Journal 50 (Suppl. 1): 70(1974).PubMedGoogle Scholar
  29. Hamilton-Miller, J.M.T.: Physiological Properties of Mutagen-induced variants of Candida albicans resistant to polyene antibiotics. Journal of Medical Microbiology 5: 425 (1972).PubMedCrossRefGoogle Scholar
  30. Harkness, R.A. and Renz, M.: Endocrine effects of the antimycotic compound clotrimazole, and its related effects on enzymic activities in leucocytes. Brit. J. clin. Pharmacol. 1: 342 (1974).Google Scholar
  31. Higton, B.K.: A trial of clotrimazole and nystatin in vaginal moniliasis. Journal of Obstetrics and Gynaecology of the British Commonwealth 80: 992 (1973).PubMedCrossRefGoogle Scholar
  32. Hirsch, A.; Szalmay, G. and Dedes, M.: Treatment of genital mycosis with clotrimazole (Bay b 5097 ). VIIth International Congress in Chemotherapy, Prague, 1971, p.253 (1971).Google Scholar
  33. Holt, R.J. and Newman, R.L.: The treatment of urinary candidosis with the oral antifungal drugs 5-fluorosytosine and clotrimazole. Developmental Medicine and Child Neurology 14: 70 (1972a).CrossRefGoogle Scholar
  34. Holt, R.J. and Newman, R.L.: Urinary candidiasis after renal transplantation. Brit. med. J. 2: 714 (1972b).PubMedCrossRefGoogle Scholar
  35. Holt, R.J. and Newman, R.L.: Laboratory assessment of the antimycotic drug clotrimazole. Journal of Clinical Pathology 25: 1089 (1972c).PubMedCrossRefGoogle Scholar
  36. Holt, R.J.: Recent developments in antimycotic chemotherapy. Infection 2: 95 (1974).PubMedCrossRefGoogle Scholar
  37. Iwata, K.; Kanda, Y.; Yamaguchi, H. and Osumi, M.: Electronmicroscopic studies on the mechanism of action of clotrimazole on Candida albicans. Sabouraudia 11: 205 (1973b).PubMedCrossRefGoogle Scholar
  38. Iwata, K.; Yamaguchi, H. and Hiratani, T.: Mode of action of clotrimazole. Sabouraudia 11: 158 (1973a).PubMedCrossRefGoogle Scholar
  39. Jamieson, A. and Anderson, K.: Primary amoebic meningoencephalitis. Lancet 1: 261 (1974).PubMedCrossRefGoogle Scholar
  40. Jones, B.R.; Richards, A.B. and Clayton, Y.M.: Clotrimazole in the treatment of ocular infeciton by Aspergillus fumigatus. Postgraduate Medical Journal 50 (Suppl. 1): 39 (1974).PubMedGoogle Scholar
  41. Keczkes, K.; Leighton, I. and Good, C.S.: Topical treatment of dermatophytoses and candidoses. Practitioner 214: 412 (1975).PubMedGoogle Scholar
  42. Kobayashi, T. and Amenomori, Y.: Results of a clinical investigation of clotrimazole (‘Canesten’), a new anti-mycotic substance, in the therapy of vaginal fungal infections. Journal of International Medical Research 2: 366 (1974).Google Scholar
  43. Legal, H-P.: The treatment of trichomonas and Candida vaginitis with clotrimazole vaginal tablets. Postgraduate Medical Journal 50 (Suppl. 1): 81 (1974).PubMedGoogle Scholar
  44. Liljedahl, SO.; Frisk, Å. and Wickman, K.: Successful treatment of Candida septicaemia in severely burned patients with a new antimycotic, clotrimazole (Bay b 5097 ). Injury: The British Journal of Accident Surgery 4: 157(1972).Google Scholar
  45. Lohmeyer, H.: Treatment of candidiasis and trichomoniasis of the female genital tract. Postgraduate Medical Journal 50 (Suppl. 1): 78 (1974).PubMedGoogle Scholar
  46. Male, O.: A double-blind comparison of clotrimazole and tolnaftate therapy of superficial dermatophytoses. Postgrad, med. J.50 (Suppl. 1): 75 (1974).Google Scholar
  47. Marget, W. and Adam, D.: Bay b 5097, a new orally applicable antifungal substance with broadspectrum activity. Acta paediat. scand. 60: 341 (1971).PubMedCrossRefGoogle Scholar
  48. Marks, H.J.: A double-blind comparison of clotrimazole and nystatin vaginal tablets in Candida vaginitis. Postgrad. med. J. JO (Suppl. 1): 105 (1974).Google Scholar
  49. Marks, M.I.; Steer, P. and Eickhoff, T.C.: In vitro sensitivity of Torulopsis glabarata to amphotericin B, 5-fluorocytosine and clotrimazole (Bay 5097). Applied Microbiology 22: 93 (1971).PubMedGoogle Scholar
  50. Masterton, G.; Henderson, J.; Napier, I.R. and Moffet, M.: Six-day clotrimazole therapy in vaginal candidosis. Current Medical Research and Opinion 3: 83 (1975).PubMedCrossRefGoogle Scholar
  51. Meinhof, W. and Günther, D.: Treatment of chronic mucocutaneous candidiasis of children (candida granuloma) with clotrimazole. Archives for Dermatological Research 242: 293 (1972).PubMedCrossRefGoogle Scholar
  52. Milne, L.J.R.: Mycologjcal studies in the use of clotrimazole in bronchopulmonary aspergillosis and neonatal and vaginal candidiasis. Postgraduate Medical Journal 50 (Suppl. 1): 20 (1974).PubMedGoogle Scholar
  53. Nakama, T.: A clinical investigation of clotrimazole (Bay b 5097) cream on skin candidiasis. Kurume Medical Journal 19: 259 (1972).CrossRefGoogle Scholar
  54. Nishimoto, K.: Clinical experiences on the treatment of dermatomycoses with Bay b 5097 cream and solution. J. West-Japan Derm. 34: No.6 (1972).Google Scholar
  55. Oates, J.K. and Davidson, F.: Treatment of vaginal candidiasis with clotrimazole. Postgraduate Medical Journal 50 (Suppl. 1): 99 (1974).PubMedGoogle Scholar
  56. Oberste-Lehn, H.: Ideal properties of a modern antifungal agent — the therapy of mycoses with clotrimazole. Postgrad. med. J. 50 (Suppl. 1): 51 (1974).PubMedGoogle Scholar
  57. Oberste-Lehn, H.; Baggesen, I. and Plempel, M.: Preliminary clinical studies of a new oral antimycotic agent in systemic mycosis. Deutsche Medizinische Wochenschrift 14: 1361 (1969).Google Scholar
  58. Plempel, M. and Bartman, K.: Experimental studies on the antimycotic action of clotrimazole (Canesten) in vitro and after local application in vivo. Drugs Made in Germany 15: 103 (1972).Google Scholar
  59. Polemann, G.: Clinical experience in the local treatment of dermatomycoses with clotrimazole. Postgraduate Medical Journal 50 (Suppl. 1): 54 (1974).PubMedGoogle Scholar
  60. Renz, M.; Farquhar, J.W.; Cohen, M. and Harkness, R.A.: Elevation of myeloperoxidase activity in infants with oral candidiasis treated with clotrimazole. Postgrad. med. J. 50 (Suppl. 1): 30 (1974).PubMedGoogle Scholar
  61. Schnell, J.D.: The incidence of vaginal Candida and trichomonas infections and treatment of trichomonas vaginitis with clotrimazole. Postgraduate Medical Journal 50 (Suppl. 1): 79 (1974).PubMedGoogle Scholar
  62. Shadomy, S.: In vitro antifungal activity of clotrimazole (Bay b 5097). Infect. Immun. 4: 143 (1971a).PubMedGoogle Scholar
  63. Shadomy, S.: In vivo studies with Bay b 5097. Antimicrob. Agents Chemother. — 1970: 169 (1971b).Google Scholar
  64. Smith, E.B.; David, L.M. and Knox, J.M.: Topical clotrimazole in dermatophytosis in a prison environment. Postgrad. med. J.50 (Suppl. 1): 64 (1974).PubMedGoogle Scholar
  65. Tamura, S.; Kwamoto, H.; Yamada, T.; Majima, H. and Miyamoto, H.: Therapy of candida vaginitis and Candida vulvovaginitis with a new antimycotic substance, clotrimazole. Current Medical Research and Opinion 1: 540 (1973).PubMedCrossRefGoogle Scholar
  66. Tan, C.G.; Good, C.S.; Milne, L.J.R. and Loudon, J.D.O.: A comparative trial of six day therapy with clotrimazole and nystatin in pregnant patients with vaginal candidiasis. Postgraduate Medical Journal 50 (Suppl. 1): 102 (1974).PubMedGoogle Scholar
  67. Tettenborn, D.: Acute toxicity and local tolerance of clotrimazole. Drugs Made in Germany 15: 94 (1972).Google Scholar
  68. Tettenborn, D.: Toxicity of clotrimazole. Postgraduate Medical Journal 50 (Suppl 1): 17(1974).PubMedGoogle Scholar
  69. Von Kunicki, A.: Ergebnisse der clotrimazol-therapie bei Candida- und Trichomonas-infektionen. Arzneimittel-Forschung (Drug Research) 24: 534 (1974).Google Scholar
  70. Von Lachenicht, P. and Potel, J.: Untersuchungen zur lokalen Chemotherapie und zur epidemiologie der weiblichen genitalmykose. Arzneimittel-Forschung (Drug Research) 24: 525 (1974).Google Scholar
  71. Wahlberg, J.E.: Irritation threshold, tolerance and cross-reactions with clotrimazole applied to skin. Postgraduate Medical Journal 50 (Suppl.1): 53 (1974).PubMedGoogle Scholar
  72. Waitz, J.A.; Moss, E.L. and Weinstein, M.J.: Chemotherapeutic evaluation of clotrimazole (Bay b 5097, l(o-chloro-α-α-diphenylbenzyl) imidazole). Applied Microbiology 22: 891 (1971).PubMedGoogle Scholar
  73. Weingartner, L.; Sitka, U.; Patsch, R. and Grundig, C.: Studies on the activity of a new antimycotic (Bay b 5097) in children. International Journal of Clinical Pharmacology, Therapy and Toxicology 6: 358 (1972).PubMedGoogle Scholar
  74. Weuta, H.: Clotrimazole vaginal tablets — clinical investigation in an open study. Drugs Made in Germany 15: 121 (1972).Google Scholar
  75. Weuta, H.: Clinical studies with oral clotrimazole. Postgraduate Medical Journal 50 (Suppl. 1): 45 (1974).PubMedGoogle Scholar
  76. Widholm, O.: An open trial of local therapy with clotrimazole for vaginal candidiasis. Postgraduate Medical Journal 50 (Suppl. 1): 85 (1974).PubMedGoogle Scholar
  77. Woutters, A.: Comparison of activity of various trichomonacides in vitro. International Symposium on Diagnosis and Chemotherapy of Urinary and Genital Infections due to Protozoa — Fungi and Bacteria, Florence, May 1971.Google Scholar
  78. Yamaguchi, H; Kanda, Y.; Iwata, K. and Osumi, M.: Electronmicroscopical studies on the fungitoxicity of bisphenyl-[2-chlorophenyl]-1-imidazolyl methane (Bay b 5097): preferential effect on the nuclear envelope in Candida albicans cells. Journal of Electron Microscopy 22: 167 (1973).PubMedGoogle Scholar

Copyright information

© Adis Press 1975

Authors and Affiliations

  • Phyllis R. Sawyer
    • 1
  • R. N. Brogden
    • 1
  • K. M. Pinder
    • 1
  • T. M. Speight
    • 1
  • G. S. Avery
    • 1
  1. 1.Australasian Drug Information ServicesBirkenhead, Auckland 10New Zealand

Personalised recommendations